留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

原发性肝癌合并胆管癌栓的临床诊治

陈书德 张文智 杨广运 许声江 林一鹏

陈书德, 张文智, 杨广运, 许声江, 林一鹏. 原发性肝癌合并胆管癌栓的临床诊治[J]. 分子影像学杂志, 2019, 42(4): 495-497. doi: 10.12122/j.issn.1674-4500.2019.04.18
引用本文: 陈书德, 张文智, 杨广运, 许声江, 林一鹏. 原发性肝癌合并胆管癌栓的临床诊治[J]. 分子影像学杂志, 2019, 42(4): 495-497. doi: 10.12122/j.issn.1674-4500.2019.04.18
Shude CHEN, Wenzhi ZHANG, Guangyun YANG, Shengjiang XU, Yipeng LIN. Clinical diagnosis and treatment of hepatocellular carcinoma combined with bile duct tumor thrombi[J]. Journal of Molecular Imaging, 2019, 42(4): 495-497. doi: 10.12122/j.issn.1674-4500.2019.04.18
Citation: Shude CHEN, Wenzhi ZHANG, Guangyun YANG, Shengjiang XU, Yipeng LIN. Clinical diagnosis and treatment of hepatocellular carcinoma combined with bile duct tumor thrombi[J]. Journal of Molecular Imaging, 2019, 42(4): 495-497. doi: 10.12122/j.issn.1674-4500.2019.04.18

原发性肝癌合并胆管癌栓的临床诊治

doi: 10.12122/j.issn.1674-4500.2019.04.18
基金项目: 海南省重点研发项目(ZDYF2017134)
详细信息
    作者简介:

    陈书德,硕士,主治医师,E-mail:chensd425@126.com

Clinical diagnosis and treatment of hepatocellular carcinoma combined with bile duct tumor thrombi

  • 摘要: 目的探讨原发性肝癌合并胆管癌栓临床诊治策略的选择。方法回顾性分析2016年8月~2019年8月解放军总院海南医院肝胆外科20例原发性肝癌合并胆管癌栓患者的外科诊治情况。结果20例均行外科手术,4例行左(右)半肝切除+胆管取栓,7例行肝脏肿瘤切除+胆管取栓,4例行肝脏肿瘤射频消融+胆管取栓,3例单纯行胆管切开取栓+T管引流术,2例行经皮经肝胆管引流术。术后随访至今,其中左(右)半肝切除及胆管取栓患者平均生存时间36.2月,肝脏肿瘤切除及胆管取栓平均生存时间34.6月,肝脏肿瘤射频消融及胆管取栓平均生存时间28.2月,单纯行胆管取栓平均生存时间13.6月,经皮经肝胆管引流减黄平均生存时间5.8月。结论原发性肝癌合并胆管癌栓,早期诊断,积极切除肿瘤及清除胆管癌栓可获得较好的临床疗效。

     

  • 图  1  1例原发性肝癌伴胆管癌栓行肝肿瘤切除、癌栓取出

    A: MRI显示胆管癌栓(箭头所指); B: 术中癌栓(箭头所指); C: 完整取出的癌栓

    表  1  患者预后资料

    手术方式例数(n平均生存时间(月)1年生存率(%)3年生存率(%)
    左右半肝切除+取栓436.275.050.0
    肝脏肿瘤切除+取栓734.671.442.8
    肝癌射频消融+取栓428.075.050.0
    胆总管切开取栓313.666.70
    经皮经肝穿刺胆管引流25.800
    下载: 导出CSV
  • [1] 彭淑牖, 王建伟, 刘颖斌, 等. 原发性肝癌伴胆管癌栓的外科治疗[J]. 中华外科杂志, 2003, 41(3): 169-71. doi: 10.3760/j:issn:0529-5815.2003.03.004
    [2] Qiao W, Yu F, Wu L, et al. Surgical outcomes of hepatocellular carcinoma with biliary tumor thrombus: a systematic review[J]. BMC Gastroenterol, 2016, 16(2): 11-23.
    [3] Navadgi S, Chang CC, Bartlett A, et al. Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus[J]. HPB (Oxford), 2016, 18(4): 312-6. doi: 10.1016/j.hpb.2015.12.003
    [4] 谭蔚锋, 罗祥基, 张柏和, 等. 原发性肝癌合并胆管癌栓不同疗法的效果比较[J]. 中国普通外科杂志, 2008, 17(10): 1033-6.
    [5] Kim JM, Cho JY, Gwak GY, et al. Incidental microscopic bile duct tumor thrombi in hepatocellular carcinoma after curative hepatectomy: a matched study[J]. Medicine, 2014, 60(1, SI): 874-85.
    [6] Lin TY, Chen KM, Chen YR, et al. Icteric type hepatoma[J]. Med Chir Dig, 1975, 4(5/6): 267-70.
    [7] An J, Lee KS, Kim KM, et al. Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion[J]. Clin Mol Hepatol, 2017, 23(2): 160-9. doi: 10.3350/cmh.2016.0088
    [8] Shao W, Sui C, Liu Z, et al. Surgical outcome of hepatocellular carcinoma patients with biliary tumor thrombi[J]. World J Surg Oncol, 2011, 9(2): 819-30.
    [9] Qin LX, Tang ZY. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis[J]. World J Gastroenterol, 2003, 9(3): 385-91. doi: 10.3748/wjg.v9.i3.385
    [10] Peng BG, Liang LJ, Li SQ, et al. Surgical treatment of hepatocellular carcinoma with bile duct tumor thrombi[J]. World J Gastroenterol, 2005, 11(25): 3966-9. doi: 10.3748/wjg.v11.i25.3966
    [11] Huang JF, Wang LY, Lin ZY, et al. Incidence and clinical outcome of icteric type hepatocellular carcinoma[J]. Gastroenterol Hepatol, 2002, 17(2): 190-5. doi: 10.1046/j.1440-1746.2002.02677.x
    [12] Oba A, Takahashi S, Kato Y, et al. Usefulness of resection for hepatocellular carcinoma with macroscopic bile duct tumor thrombus[J]. Anticancer Res, 2014, 34(8): 4367-72.
    [13] Long XY, Li YX, Wu W, et al. Diagnosis of bile duct hepatocellular carcinoma thrombus without obvious intrahepatic mass[J]. World J Gastroenterol, 2010, 16(39): 4998-5004. doi: 10.3748/wjg.v16.i39.4998
    [14] Wu Z, Guo K, Sun H, et al. Caution for diagnosis and surgical treatment of recurrent cholangitis: lessons from 5 cases of bile duct tumor thrombus without a detectable intrahepatic tumor[J]. Medicine, 2014, 93(11): e80-91. doi: 10.1097/MD.0000000000000080
    [15] Ueda M, Takeuchi T, Takayasu T, et al. Classification and surgical treatment of hepatocellular carcinoma with bile duct thrombi[J]. Hepatogastroenterol, 1994, 41(5): 349-54.
    [16] 卢 俊, 于光圣. 肝细胞癌合并胆管癌栓的外科治疗进展[J]. 中国现代普通外科进展, 2009, 12(9): 800-2. doi: 10.3969/j.issn.1009-9905.2009.09.019
    [17] Uchima-Koecklin H, Balderramo D, Cárdenas A. Bile duct hepatocellular carcinoma thrombi[J]. Gastroenterol Hepatol, 2012, 35(5): 326-9. doi: 10.1016/j.gastrohep.2011.12.004
    [18] 王 坤. 原发性肝癌并胆管癌栓的临床诊治分析: 附19例报告[J]. 现代肿瘤医学, 2017, 25(1): 73-6. doi: 10.3969/j.issn.1672-4992.2017.01.020
    [19] Gabata T, Terayama N, Kobayashi S, et al. Mr imaging of hepatocellular carcinomas with biliary tumor thrombi[J]. Abdom Imaging, 2007, 32(4): 470-4. doi: 10.1007/s00261-006-9154-4
    [20] Liu QY, Huang SQ, Chen JY, et al. Small hepatocellular carcinoma with bile duct tumor thrombi: CT and MRI findings[J]. Abdom Imaging, 2010, 35(5): 537-42. doi: 10.1007/s00261-009-9571-2
    [21] Wong TC, Cheung TT, Chok KS, et al. Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus[J]. HPB (Oxford), 2015, 17(5): 401-8. doi: 10.1111/hpb.12368
    [22] Wang C, Yang Y, Sun D, et al. Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: a meta-analysis[J]. PLoS One, 2017, 12(5): e0176827-38. doi: 10.1371/journal.pone.0176827
    [23] Orimo T, Kamiyama T, Yokoo H, et al. Hepatectomy for hepatocellular carcinoma with bile duct tumor thrombus, including cases with obstructive jaundice[J]. Ann Surg Oncol, 2016, 23(8): 2627-34. doi: 10.1245/s10434-016-5174-7
    [24] Ikenaga N, Chijiiwa K, Otani K, et al. Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion[J]. J Gastrointest Surg, 2009, 13(3): 492-7. doi: 10.1007/s11605-008-0751-0
    [25] Xu LB, Wang J, Liu C, et al. Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery[J]. World J Gastroenterol, 2010, 16(41): 5257-62. doi: 10.3748/wjg.v16.i41.5257
  • 加载中
图(1) / 表(1)
计量
  • 文章访问数:  892
  • HTML全文浏览量:  315
  • PDF下载量:  8
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-09-10
  • 刊出日期:  2019-12-01

目录

    /

    返回文章
    返回

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者:

    为了缩短出版时滞,促进科研成果的快速传播,我刊自2024年1月起,刊期由双月刊变更为月刊。本刊主要栏目有:基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱!

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日